S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
NASDAQ:AQB

AquaBounty Technologies (AQB) Stock Price, News & Analysis

$1.71
-0.04 (-2.29%)
(As of 01:35 PM ET)
Today's Range
$1.69
$1.75
50-Day Range
$1.74
$2.62
52-Week Range
$1.57
$11.90
Volume
14,299 shs
Average Volume
30,462 shs
Market Capitalization
$6.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.00

AquaBounty Technologies MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
1,362.0% Upside
$25.00 Price Target
Short Interest
Healthy
4.27% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.00mentions of AquaBounty Technologies in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($4.50) to ($4.15) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.89 out of 5 stars

AQB stock logo

About AquaBounty Technologies Stock (NASDAQ:AQB)

AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. It engages in genetic, genomic, and fish health and nutrition research activities. The company also operates salmon farms using proprietary technology. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.

AQB Stock Price History

AQB Stock News Headlines

AquaBounty Technologies Inc
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
AQB Mar 2024 2.500 put
AquaBounty Technologies Provides Fundraising Update
11 Highest Quality Caviars in the World
Strange new buyer driving up gold
One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."
AQB and BTCT among Consumer Staples movers
AquaBounty Technologies Inc AQB
AquaBounty Technologies Announces Reverse Stock Split
AQB - AquaBounty Technologies, Inc.
Fish Consumption by Country Per Capita: Top 20
See More Headlines
Receive AQB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AquaBounty Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
4/19/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Fishing, hunting & trapping
Sub-Industry
N/A
Current Symbol
NASDAQ:AQB
Fax
N/A
Employees
104
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$25.00
High Stock Price Target
$30.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+1,328.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-27,560,000.00
Net Margins
-1,114.81%
Pretax Margin
-1,114.35%

Debt

Sales & Book Value

Annual Sales
$2.47 million
Book Value
$42.90 per share

Miscellaneous

Free Float
3,768,000
Market Cap
$6.76 million
Optionable
No Data
Beta
1.32
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Ms. Sylvia A. Wulf (Age 65)
    CEO & Chair
    Comp: $438.12k
  • Mr. David F. Melbourne Jr. (Age 57)
    President
    Comp: $342.62k
  • Mr. David A. Frank M.B.A. (Age 64)
    CFO & Treasurer
    Comp: $329.08k
  • Dr. Alejandro Rojas D.V.M. (Age 62)
    Chief Operating Officer
    Comp: $234.1k
  • Dr. Chris Beattie Ph.D.
    Chief Scientific Officer
  • Ms. Angela M. Olsen J.D. (Age 55)
    General Counsel & Corporate Secretary
    Comp: $335.37k
  • Dave Conley
    Director of Communications
  • Mr. Dennis Bryant
    Director of Sales
  • Ms. Melissa Johns Daley
    Chief People Officer

AQB Stock Analysis - Frequently Asked Questions

Should I buy or sell AquaBounty Technologies stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AQB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AQB, but not buy additional shares or sell existing shares.
View AQB analyst ratings
or view top-rated stocks.

What is AquaBounty Technologies' stock price target for 2024?

3 Wall Street analysts have issued 12 month target prices for AquaBounty Technologies' stock. Their AQB share price targets range from $20.00 to $30.00. On average, they predict the company's stock price to reach $25.00 in the next twelve months. This suggests a possible upside of 1,362.0% from the stock's current price.
View analysts price targets for AQB
or view top-rated stocks among Wall Street analysts.

How have AQB shares performed in 2024?

AquaBounty Technologies' stock was trading at $2.85 at the beginning of 2024. Since then, AQB shares have decreased by 40.0% and is now trading at $1.71.
View the best growth stocks for 2024 here
.

When is AquaBounty Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our AQB earnings forecast
.

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies, Inc. (NASDAQ:AQB) announced its earnings results on Tuesday, November, 7th. The company reported ($1.60) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.94) by $0.34. The business earned $0.73 million during the quarter, compared to the consensus estimate of $0.65 million. AquaBounty Technologies had a negative trailing twelve-month return on equity of 15.68% and a negative net margin of 1,114.81%.

When did AquaBounty Technologies' stock split?

Shares of AquaBounty Technologies reverse split before market open on Monday, October 16th 2023. The 1-20 reverse split was announced on Monday, October 16th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 16th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AquaBounty Technologies investors own include Celldex Therapeutics (CLDX), Precigen (PGEN), ZIOPHARM Oncology (ZIOP), AbbVie (ABBV), Ocular Therapeutix (OCUL), AT&T (T), Allena Pharmaceuticals (ALNA), Evofem Biosciences (EVFM) and Rigel Pharmaceuticals (RIGL).

How do I buy shares of AquaBounty Technologies?

Shares of AQB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AQB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners